
POMALIDOMIDE 4 mg (Pomalid) is a prescription immunomodulatory anticancer medicine used to treat relapsed or refractory multiple myeloma in patients who have received previous therapies. It is commonly prescribed in combination with dexamethasone or other anticancer medicines to help slow disease progression and improve treatment response. It should be used only under the supervision of an oncologist.
| Generic name | POMALIDOMIDE |
| Strength | 4 mg |
| Manufacturer | Natco |
| Package size | 21 Capsules |
| Used for | Multiple myeloma and Kaposi sarcoma |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Pomalidomide 4 mg works by modifying the body’s immune response, inhibiting the growth and survival of multiple myeloma cells, and reducing the formation of new blood vessels that support tumour growth. These combined actions help slow cancer progression and improve disease control.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.